Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Conditions:   Attention Deficit Disorder With Hyperactivity;   Conduct Disorder;   Substance Abuse Intervention:   Drug: Adderall Sponsors:   Jeffrey Newcorn;   National Institute on Drug Abuse (NIDA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2019 Category: Research Source Type: clinical trials

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: Methylphenidate;   Drug: Lisdexamfetamine;   Drug: Atomoxetine;   Drug: Amphetamine;   Drug: Dextroamphetamine Sponsor:   Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2019 Category: Research Source Type: clinical trials

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
Conditions:   Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy Interventions:   Drug: Modafinil;   Drug: Amphetamine-Dextroamphetamine Sponsors:   Emory University;   American Academy of Sleep Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials

Neuroimaging the Expectancy Versus Pharmacotherapy Effect of Adderall on Cognitive Performance
Condition:   Expectancy Versus Pharmacotherapy Effect of Adderall Interventions:   Drug: Adderall;   Drug: Placebo Sponsor:   University of Alabama at Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2018 Category: Research Source Type: clinical trials